CATX: Perspective Therapeutics, Inc. Company Profile & Statistics

Perspective Therapeutics, Inc. Profile

About

Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc., formerly known as Isoray Inc., is based in RICHLAND, Wash.

Info & Links

CEO

Johan Thijs Spoor

Headquarters

2401 ELLIOTT AVENUE, SUITE 320
SEATTLE, WA 98121, UNITED STATES

Auditor

Assure CPA, LLC

Share holders

Employees

140

Perspective Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization²

261.41M

Enterprise Value

234.21M

Enterprise Value/EBITDA(ttm)

-2.76

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

202.64

Price to Book(mrq)

0.94

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-7899.92%

Profit Margin(ttm)

-8496.97%

Return on Equity(ttm)

-33.37%

Return on Invested Capital(ttm)

-33.62%

Return on Assets(ttm)

-28.44%

Income Statement

Revenue(ttm)

1.23M

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

1.23M

EBITDA(ttm)³

-84.96M

Net Income Available to Common(ttm)

-94.95M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

1.20

52-Week Change

-76.69%

S&P 500 52-Week Change

17.30%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

74.26M

Dividend Yield

0.00%

Float⁴

71.50M

% Held by Insiders

3.72%

% Held by Institutions

54.66%

Balance Sheet

Total Cash(mrq)

191.58M

Total Cash Per Share(mrq)

2.58

Total Debt(mrq)

1.65M

Total Debt/Equity(mrq)

0.62%

Current Ratio(mrq)

15.09%

Quick Ratio(mrq)

15.09%

Book Value Per Share(mrq)

3.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.56

Free Cash Flow(ytd)

-47.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CATX

Perspective Therapeutics, Inc.